Hyperspectral Imaging Reveals Spectral Differences and Can Distinguish Malignant Melanoma from Pigmented Basal Cell Carcinomas: A Pilot Study

Pigmented basal cell carcinomas can be difficult to distinguish from melanocytic tumours. Hyperspectral imaging is a non-invasive imaging technique that measures the reflectance spectra of skin in vivo. The aim of this prospective pilot study was to use a convolutional neural network classifier in h...

Full description

Bibliographic Details
Main Authors: Janne Räsänen, Mari Salmivuori, Ilkka Pölönen, Mari Grönroos, Noora Neittaanmäki
Format: Article
Language:English
Published: Medical Journals Sweden 2021-02-01
Series:Acta Dermato-Venereologica
Subjects:
Online Access: https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3755
_version_ 1819279370046406656
author Janne Räsänen
Mari Salmivuori
Ilkka Pölönen
Mari Grönroos
Noora Neittaanmäki
author_facet Janne Räsänen
Mari Salmivuori
Ilkka Pölönen
Mari Grönroos
Noora Neittaanmäki
author_sort Janne Räsänen
collection DOAJ
description Pigmented basal cell carcinomas can be difficult to distinguish from melanocytic tumours. Hyperspectral imaging is a non-invasive imaging technique that measures the reflectance spectra of skin in vivo. The aim of this prospective pilot study was to use a convolutional neural network classifier in hyperspectral images for differential diagnosis between pigment­ed basal cell carcinomas and melanoma. A total of 26 pigmented lesions (10 pigmented basal cell carcinomas, 12 melanomas in situ, 4 invasive melanomas) were imaged with hyperspectral imaging and excised for histopatho­logical diagnosis. For 2-class classifier (melano­cytic tumours vs pigmented basal cell carcinomas) using the majority of the pixels to predict the class of the whole lesion, the results showed a sensitivity of 100% (95% confidence interval 81–100%), specificity of 90% (95% confidence interval 60–98%) and positive predictive value of 94% (95% confidence interval 73–99%). These results indicate that a convolutional neural network classifier can differentiate melanocytic tumours from pigmented basal cell carcinomas in hyperspectral images. Further studies are warranted in order to confirm these preliminary results, using larger samples and multiple tumour types, including all types of melanocytic lesions.
first_indexed 2024-12-24T00:26:49Z
format Article
id doaj.art-0cce763b8bb34c2e93c50b87063f98ea
institution Directory Open Access Journal
issn 0001-5555
1651-2057
language English
last_indexed 2024-12-24T00:26:49Z
publishDate 2021-02-01
publisher Medical Journals Sweden
record_format Article
series Acta Dermato-Venereologica
spelling doaj.art-0cce763b8bb34c2e93c50b87063f98ea2022-12-21T17:24:24ZengMedical Journals SwedenActa Dermato-Venereologica0001-55551651-20572021-02-011012adv0040510.2340/00015555-37556000Hyperspectral Imaging Reveals Spectral Differences and Can Distinguish Malignant Melanoma from Pigmented Basal Cell Carcinomas: A Pilot StudyJanne Räsänen0Mari SalmivuoriIlkka PölönenMari GrönroosNoora Neittaanmäki Department of Dermatology, Tampere University Hospital, FIN-33530 Tampere, Finland. E-mail: janne.rasanen@sll.fimnet.fi. Pigmented basal cell carcinomas can be difficult to distinguish from melanocytic tumours. Hyperspectral imaging is a non-invasive imaging technique that measures the reflectance spectra of skin in vivo. The aim of this prospective pilot study was to use a convolutional neural network classifier in hyperspectral images for differential diagnosis between pigment­ed basal cell carcinomas and melanoma. A total of 26 pigmented lesions (10 pigmented basal cell carcinomas, 12 melanomas in situ, 4 invasive melanomas) were imaged with hyperspectral imaging and excised for histopatho­logical diagnosis. For 2-class classifier (melano­cytic tumours vs pigmented basal cell carcinomas) using the majority of the pixels to predict the class of the whole lesion, the results showed a sensitivity of 100% (95% confidence interval 81–100%), specificity of 90% (95% confidence interval 60–98%) and positive predictive value of 94% (95% confidence interval 73–99%). These results indicate that a convolutional neural network classifier can differentiate melanocytic tumours from pigmented basal cell carcinomas in hyperspectral images. Further studies are warranted in order to confirm these preliminary results, using larger samples and multiple tumour types, including all types of melanocytic lesions. https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3755 deep learning neural network basal cell carcinoma malignant melanoma
spellingShingle Janne Räsänen
Mari Salmivuori
Ilkka Pölönen
Mari Grönroos
Noora Neittaanmäki
Hyperspectral Imaging Reveals Spectral Differences and Can Distinguish Malignant Melanoma from Pigmented Basal Cell Carcinomas: A Pilot Study
Acta Dermato-Venereologica
deep learning
neural network
basal cell carcinoma
malignant melanoma
title Hyperspectral Imaging Reveals Spectral Differences and Can Distinguish Malignant Melanoma from Pigmented Basal Cell Carcinomas: A Pilot Study
title_full Hyperspectral Imaging Reveals Spectral Differences and Can Distinguish Malignant Melanoma from Pigmented Basal Cell Carcinomas: A Pilot Study
title_fullStr Hyperspectral Imaging Reveals Spectral Differences and Can Distinguish Malignant Melanoma from Pigmented Basal Cell Carcinomas: A Pilot Study
title_full_unstemmed Hyperspectral Imaging Reveals Spectral Differences and Can Distinguish Malignant Melanoma from Pigmented Basal Cell Carcinomas: A Pilot Study
title_short Hyperspectral Imaging Reveals Spectral Differences and Can Distinguish Malignant Melanoma from Pigmented Basal Cell Carcinomas: A Pilot Study
title_sort hyperspectral imaging reveals spectral differences and can distinguish malignant melanoma from pigmented basal cell carcinomas a pilot study
topic deep learning
neural network
basal cell carcinoma
malignant melanoma
url https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3755
work_keys_str_mv AT jannerasanen hyperspectralimagingrevealsspectraldifferencesandcandistinguishmalignantmelanomafrompigmentedbasalcellcarcinomasapilotstudy
AT marisalmivuori hyperspectralimagingrevealsspectraldifferencesandcandistinguishmalignantmelanomafrompigmentedbasalcellcarcinomasapilotstudy
AT ilkkapolonen hyperspectralimagingrevealsspectraldifferencesandcandistinguishmalignantmelanomafrompigmentedbasalcellcarcinomasapilotstudy
AT marigronroos hyperspectralimagingrevealsspectraldifferencesandcandistinguishmalignantmelanomafrompigmentedbasalcellcarcinomasapilotstudy
AT nooraneittaanmaki hyperspectralimagingrevealsspectraldifferencesandcandistinguishmalignantmelanomafrompigmentedbasalcellcarcinomasapilotstudy